Duke has two immediate openings for talented researchers interested in zoonotic diseases

 ·         One Health research analyst/study coordinator (masters level or higher to work at Duke University) – See attached

·         One Health US postdoctoral fellow to work with our five other fellows in Mongolia – See http://www.onehealthinitiative.com/publications/FY16%20Duke%20US%20citizen%20postdoctoral%20position%20PD%20replacement.pdf

 Provided by:

International Association of Risk Management in Medicine (IARMM) Endorses One Health Initiative

International Association of Risk Management in Medicine (IARMM)

(Postal address) Hongo 4-7-12-102, Tokyo 113-0033, Japan

(E-mail) head.office01@iarmm.org/ manager@iarmm.net

(Tel/Fax)+81-3-3817-6770(URL) www.iarmm.org

International Association of Risk Management in Medicine (IARMM) Endorses One Health Initiative

International Association of Risk Management in Medicine (IARMM)

(Postal address) Hongo 4-7-12-102, Tokyo 113-0033, Japan

(E-mail) head.office01@iarmm.org/ manager@iarmm.net

(Tel/Fax)+81-3-3817-6770(URL) www.iarmm.org

The Editors of Intima: A Journal of Narrative Medicine Announcement

2016 Intima Essay Contest

"Patients, Providers and Pets: One Health for All"

Call for Submissions: January 8-February 8, 2016       Winner announced on March 1, 2016

For more information see http://www.theintima.org/

Provided by:

Zohar Lederman, MD

PhD candidate, Centre for Biomedical Ethics,

National University of Singapore

Outstanding One Health Program– University of Wisconsin, Madison Libraries (USA)

 SEE: http://researchguides.library.wisc.edu/onehealth

Parasites & Vectors Journal – Open Access

Quantitative analysis of strategies to achieve the 2020 goals for neglected tropical diseases: where are we now?

Edited by: Deirdre Hollingsworth, PhD https://www2.warwick.ac.uk/fac/sci/maths/people/staff/hollingsworth/; https://www2.warwick.ac.uk/fac/sci/lifesci/people/dhollingsworth/  

This thematic collection of papers aims to provide quantitative analyses to support policy development in the run up to the 2020 goals for neglected tropical diseases laid out by the World Health Organisation and supported in the London Declaration. This collection focuses on the nine diseases in the London Declaration targeted for control or elimination as a public health problem, reducing the burden of disease. The implications of these analyses are summarised in the overarching article, which serves an introduction to the collection for both non-modellers and modellers who are new to neglected tropical diseases.

For the preventive chemotherapy diseases (PCT) or mass drug administration (MDA) diseases (lymphatic filariasis, onchocerciasis, soil-transmitted helminths, schistosomiasis and trachoma), the issues faced by the programmes are how frequently treatments should be given, to whom should they be given, for how many rounds, as well as methods for estimating the impact of the current programmes. In this collection there are analyses which estimate the impact of current strategies, and the feasibility of achieving the 2020 targets under current and altered strategies.

For the intensified disease management diseases (leprosy, human African trypanosomiasis, visceral leishmaniasis and Chagas disease), there are more fundamental questions around the natural history of disease and the transmission dynamics to be addressed. In this collection there are papers providing new estimates for key parameters, such as incubation periods and true underlying incidence, as well as papers studying the consequences of different model structures to investigate hypotheses about the transmission dynamics.

This collection is the result of a recent and growing international collaboration of researchers within the NTD Modelling Consortium. The authors and guest editor gratefully acknowledge funding of the NTD Modelling Consortium by the Bill and Melinda Gates Foundation in partnership with the Task Force for Global Health, by Novartis Foundation and by Children’s Investment Fund Foundation (UK) ("CIFF"). The views, opinions, assumptions or any other information set out in this collection are solely those of the authors.

Collection published: 22 October 2015 Last updated: 9 December 2015

Please see complete publication(s) http://www.parasitesandvectors.com/series/ntdmodels2015

U.S. Centers for Disease Control & Prevention (CDC) – Morbidity and Mortality Report

Notes from the Field: Increase in Human Cases of Tularemia — Colorado, Nebraska, South Dakota, and Wyoming, January–September 2015

December 4, 2015 / 64(47);1317-8

Caitlin Pedati, MD1,2; Jennifer House, DVM3; Jessica Hancock-Allen, MPH1,3; Leah Colton, PhD3; Katie Bryan, MPH4; Dustin Ortbahn5; Lon Kightlinger, PhD5; Kiersten Kugeler, PhD6; Jeannine Petersen, PhD6; Paul Mead, MD6; Tom Safranek MD2; Bryan Buss DVM2,7

“Tularemia is a rare, often serious disease caused by a gram-negative coccobacillus, Francisella tularensis, which infects humans and animals in the Northern Hemisphere (1). Approximately 125 cases have been reported annually in the United States during the last two decades (2). As of September 30, a total of 100 tularemia cases were reported in 2015 among residents of Colorado (n = 43), Nebraska (n = 21), South Dakota (n = 20), and Wyoming (n = 16) (Figure). This represents a substantial increase in the annual mean number of four (975% increase), seven (200%), seven (186%) and two (70%) cases, respectively, reported in each state during 2004–2014 (2). ...

See complete article: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6447a4.htm

George Luedekke, PhD SHORT BIO Dec 22, 2015

An Outstanding “One Health” program...                              

UC Davis School of Veterinary Medicine (USA)

The One Health movement and excellent “One Health” activities are discussed in this comprehensive report that is created every 5-7 years.

“...The UC Davis School of Veterinary Medicine has a One Health Institute http://www.vetmed.ucdavis.edu/ohi/ , which is active all over the world.”

http://www.ucop.edu/uc-health/_files/vet-med-an-era-of-change.pdf

Important Open-Access/Elsevier B.V. One Health Journal notice...

The ‘One Health’ journal: Filling a niche

The Chief Editors of ‘One Health’: Ab Osterhaus, PhD http://www.eswi.org/about-eswi/eswis-members-and-associate-members/dr-albert-osterhaus and John MacKenzie, PhD http://www.journals.elsevier.com/one-health/editorial-board/john-mackenzie/ are internationally recognized eminent virologist/microbiolgists. 

Managing Editor, Leslie A. Reperant, DVM, PhD http://www.journals.elsevier.com/one-health/editorial-board/leslie-reperant/

Received 18 November 2015, Accepted 18 November 2015, Available online 24 November 2015"Welcome to the first issue of ‘One Health’, the official journal of the One Health Platform, a foundation that was established at the occasion of the Third International One Health Congress, held in Amsterdam earlier this year. The journal is part of the larger, community-wide initiative which includes the One Health Platform and the One Health Congress series. ...”

The One Health Platform http://onehealthplatform.com/?page_id=346 is a strategic forum of stakeholders and a One Health reference network that aims to enhance and network our understanding of, and preparedness for, current and future outbreaks of zoonoses, emerging infectious diseases in humans and animals, as well as antimicrobial resistance, including the ecological, environmental and societal drivers behind these phenomena. The One Health Congress series consists of biennial international meetings designed for members of the One Health community, with a scientific programme based on the One Health Platform research agenda and a separate Science Policy Interface track for public health officials and decision makers. ...”

...The ‘One Health’ journal aims to become a high impact journal that fills the niche of this rapidly evolving field of knowledge, based on the recognition that human, animal and ecosystem health are inextricably linked, and can have profound effects on human society. ...”

Please read full description http://www.sciencedirect.com/science/article/pii/S2352771415300185

“The journal accepted 14 high quality papers since its launch in May 2015 and now has its first issue published. The line-up of papers is impressive...check out ScienceDirect page at: http://www.sciencedirect.com/science/journal/23527714/1”

*NOTE: Drs. Osterhaus, MacKenzie and Reperant are valued One Health supporter/advocates http://www.onehealthinitiative.com/supporters.php.